Disulfiram Treatment Normalizes Body Weight in Obese Mice.

[1]  M. Colado,et al.  Changes in brain kynurenine levels via gut microbiota and gut‐barrier disruption induced by chronic ethanol exposure in mice , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  E. Ravussin,et al.  Progress and challenges in analyzing rodent energy expenditure , 2019, Nature Methods.

[3]  Amir I Mina,et al.  CalR: A Web-based Analysis Tool for Indirect Calorimetry Experiments , 2017, bioRxiv.

[4]  B. Pineda,et al.  Kynurenine pathway metabolites and enzymes involved in redox reactions , 2017, Neuropharmacology.

[5]  F. Tacke,et al.  Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells , 2016, Cellular & Molecular Immunology.

[6]  K. Kaestner,et al.  Effects of ageing and senescence on pancreatic β‐cell function , 2016, Diabetes, obesity & metabolism.

[7]  S. Simpson,et al.  Small Vessels – Big Problems : Novel Insights into Microvascular Mechanisms of Diseases Dietary macronutrients and the aging liver sinusoidal endothelial cell X , 2016 .

[8]  G. Weir.  Islet-cell biology in 2015: Understanding secretion, ageing and death in β cells , 2016, Nature Reviews Endocrinology.

[9]  R. Putti,et al.  Diet impact on mitochondrial bioenergetics and dynamics , 2015, Front. Physiol..

[10]  Giulio Marchesini,et al.  Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[11]  S. Manti,et al.  Oxidative Stress in Obesity: A Critical Component in Human Diseases , 2014, International journal of molecular sciences.

[12]  F. Tacke,et al.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. , 2014, Hepatobiliary surgery and nutrition.

[13]  David M. Wilson,et al.  A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome. , 2014, Cell metabolism.

[14]  Surendra Singh,et al.  Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice , 2014, Hepatology.

[15]  M. Bernier,et al.  Pyrrolidine dithiocarbamate protects pancreatic β-cells from oxidative damage through regulation of FoxO1 activity in type 2 diabetes rats. , 2014, Acta biochimica et biophysica Sinica.

[16]  R. de Cabo,et al.  Longitudinal analysis of calorie restriction on rat taste bud morphology and expression of sweet taste modulators. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  U. Eriksson,et al.  Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease , 2013, Nature Protocols.

[18]  J. Mehta,et al.  ALDH2 protects against stroke by clearing 4-HNE , 2013, Cell Research.

[19]  Stuart Maudsley,et al.  Pancreas++: Automated Quantification of Pancreatic Islet Cells in Microscopy Images , 2013, Front. Physio..

[20]  Vindhya Koppaka,et al.  Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application , 2012, Pharmacological Reviews.

[21]  H. Jamieson,et al.  The liver sieve and atherosclerosis , 2012, Pathology.

[22]  M. Bernier,et al.  Pyrrolidine dithiocarbamate enhances hepatic glycogen synthesis and reduces FoxO1-mediated gene transcription in type 2 diabetic rats. , 2012, American journal of physiology. Endocrinology and metabolism.

[23]  E. Mercken,et al.  SRT1720 improves survival and healthspan of obese mice , 2011, Scientific reports.

[24]  A. Fenning,et al.  High-carbohydrate, High-fat Diet–induced Metabolic Syndrome and Cardiovascular Remodeling in Rats , 2011, Journal of cardiovascular pharmacology.

[25]  Yan Wang,et al.  Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells , 2011, Diabetes.

[26]  Juen Guo,et al.  Predicting Changes of Body Weight, Body Fat, Energy Expenditure and Metabolic Fuel Selection in C57BL/6 Mice , 2011, PloS one.

[27]  N. Lenard,et al.  Dietary methionine restriction enhances metabolic flexibility and increases uncoupled respiration in both fed and fasted states. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[28]  D. Stoffers,et al.  Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion. , 2009, Molecular endocrinology.

[29]  M. Bernier,et al.  Determination of free and protein-bound glutathione in HepG2 cells using capillary electrophoresis with laser-induced fluorescence detection. , 2009, Journal of chromatography. A.

[30]  Jie Zhou,et al.  Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease , 2009, Diabetes.

[31]  M. Benito,et al.  β-Cell Hyperplasia Induced by Hepatic Insulin Resistance , 2009, Diabetes.

[32]  B. Z. Altunkaynak,et al.  The effects of high‐fat diet on the renal structure and morphometric parametric of kidneys in rats , 2008, Journal of anatomy.

[33]  R. Kast.  Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery. , 2008, JOP : Journal of the pancreas.

[34]  Nihal Ahmad,et al.  Dose translation from animal to human studies revisited , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  H. Aburatani,et al.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. , 2007, The Journal of clinical investigation.

[36]  A. Aljada,et al.  Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .

[37]  A. Mclean,et al.  Hepatic pseudocapillarisation and atherosclerosis in ageing , 2002, The Lancet.

[38]  R. Branch,et al.  Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects. , 2002, British journal of clinical pharmacology.

[39]  K. Kitagawa,et al.  Aldehyde dehydrogenase (ALDH) 2 associates with oxidation of methoxyacetaldehyde; in vitro analysis with liver subcellular fraction derived from human and Aldh2 gene targeting mouse , 2000, FEBS letters.

[40]  E. Kharasch,et al.  Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans. , 1999, The Journal of pharmacology and experimental therapeutics.

[41]  J. Redondo,et al.  Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. , 1996, Blood.

[42]  M. D. Faiman,et al.  Glutathione- and glutathione-S-transferase-dependent oxidative desulfuration of the thione xenobiotic diethyldithiocarbamate methyl ester. , 1994, Molecular pharmacology.

[43]  D. Männel,et al.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.

[44]  R. Deitrich,et al.  Mechanism of the inhibition of aldehyde dehydrogenase in vivo by disulfiram and diethyldithiocarbamate. , 1971, Molecular pharmacology.

[45]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[46]  G. Gessa,et al.  Disulfiram for binge eating disorder: an open trail. , 2015, Eating behaviors.

[47]  S. Yanovski,et al.  Long-term drug treatment for obesity: a systematic and clinical review. , 2014, JAMA.

[48]  Julio C. B. Ferreira,et al.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. , 2014, Physiological reviews.

[49]  Yan Wang,et al.  Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells , 2011, Diabetes.

[50]  H. Poulsen,et al.  Prevention of acetaminophen hepatotoxicity by disulfiram. , 1987, Pharmacology & therapeutics.